Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule for treating H1N1 influenza A and preparation method of capsule

A technology of capsules and influenza, which is applied in the field of pharmacy, can solve the problems of high recurrence rate, painful treatment process, and unsatisfactory treatment effect, and achieve the effects of strong pertinence, rich drug sources, and less resistance to drugs

Inactive Publication Date: 2015-06-03
JINAN HONGFEI BIOTECH
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The treatment of the prior art is based on Western medicine, and the treatment mainly includes two methods, namely antiviral treatment and antibiotic treatment. The drugs used include oseltamivir (oseltamivir Tamiflu) and zanamivir (zanamivir). The patient's symptoms are relieved, but the recurrence rate is high after stopping the drug, which makes the patient very painful during the treatment process and the treatment effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The ratio of parts by weight of each raw medicinal material in the medicament is as follows: 2 parts of Gelkins, 2 parts of Ginger, 3 parts of C. 2 parts of Maiden root, 3 parts of nepeta, 2 parts of shellfish, 3 parts of tempeh ginger, 5 parts of dandelion, 2 parts of notopterygium, 1 part of white dragon head, 2 parts of Potentilla, and 3 parts of myrobalan.

[0044] The preparation process of this capsule comprises the following steps:

[0045] Step 1. Mix the above drugs in proportion, dry them in an oven at 65°C, remove impurities and let them cool down;

[0046] Step 2, pulverize the cooled mixed medicine into fine powder, pass through a 100-mesh sieve, mix well, and sterilize with ultraviolet light for later use;

[0047] Step 3. Put the gelatin powder into distilled water to make it expand. The weight ratio of gelatin powder, distilled water, and mixed medicine is 1:4:8. After the gelatin melts, add the fine powder in step 2 and stir to mix evenly ;

[0048] ...

Embodiment 2

[0052] The ratio of parts by weight of each raw material medicinal material in the medicament is: 15 parts of Gelkins, 15 parts of Ginger, 8 parts of C. 15 parts of Maiden Root, 18 parts of Nepeta, 13 parts of Shellfish, 12 parts of Douchi Jiang, 15 parts of Dandelion, 15 parts of Qianghuo, 10 parts of Bailongtou, 16 parts of Potentilla, and 13 parts of Myrobalan.

[0053] The dosage form of this traditional Chinese medicine is capsule, and its preparation method is the same as embodiment 1.

Embodiment 3

[0055] The ratio of parts by weight of each raw medicinal material in the medicament is as follows: 3 parts of Gelkins, 3 parts of Ginger, 5 parts of C. 3 parts of Maiden root, 5 parts of Nepeta, 5 parts of shellfish, 5 parts of tempeh ginger, 6 parts of dandelion, 2 parts of notopterygium, 2 parts of white dragon head, 3 parts of Potentilla, and 5 parts of myrobalan.

[0056] The dosage form of this traditional Chinese medicine is capsule, and its preparation method is the same as embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a capsule for treating H1N1 influenza A and a preparation method of the capsule. The capsule comprises the following active ingredients: gelsemium elegans, ginger, pteris multifda poir, salomonia cantoniensis lour, hispid arthraxon, white strawberry, Chinese angelica, small-leaved premna roots, herba schizonepetae, cowry shells, litsea cubeba, dandelion, notopterygium roots, Indian lettuce roots, potentilla chinensis and myrobalan. A preparation process of the capsule comprises the steps of grinding, mixing to form gelatin liquid, preparing a soft film, pressing into a finished product and the like. Compared with the prior art, the capsule has effects of strengthening body resistance, eliminating pathogenic factors, relieving an exterior syndrome, eliminating dampness, clearing a throat, clearing away heat, diffusing a lung, clearing away toxic materials and strengthening a spleen, and has better pertinency, strong practicability and an ideal treatment effect.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a capsule for treating influenza A (H1N1) and a preparation method thereof. Background technique [0002] Influenza A H1N1, disease name, commonly known as swine flu, swine flu (Swine Influenza) is an acute, zoonotic respiratory infectious disease of pigs or humans caused by type A (type A) influenza virus. This disease occurs frequently in pigs and rarely leads to death of pigs (case fatality rate of pigs is 1% to 4%). Humans are rarely infected with swine influenza virus, but some human cases have been found, mostly in people who had direct contact with sick pigs. In March 2009, humans were infected with swine influenza virus successively in Mexico and the United States, which was type A influenza virus and H1N1 subtype swine influenza virus strain, which contained three types of influenza viruses: swine influenza, avian influenza and human influenza. The gene fragment is a ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61K9/48A61P31/14
Inventor 白云霞
Owner JINAN HONGFEI BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com